James Trager
CIK 1816549 · Chief Scientific Officer · last filed 2024-06-20
James Trager is a Chief Scientific Officer who has filed 14 SEC Form 4 insider transactions across 1 company since 2020. The most recent filing shows the insider sold $2.6K of NKTX on Jun 20, 2024. Across all open-market trades the lifetime net is −$666.7K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $431.7K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$431.7K
1
14
-$666.7K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NKTX | Chief Scientific Officer | 150,959 | $2.86 | $431.7K | -$666.7K | 14 | 2024-06-20 |
Recent Filings
14 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-06-20 | NKTX | Sell (S) | −456 | -$2.6K | EDGAR |
| 2024-02-14 | NKTX | Sell (S) | −4,143 | -$49.7K | EDGAR |
| 2024-01-18 | NKTX | Sell (S) | −4,560 | -$39.9K | EDGAR |
| 2024-01-08 | NKTX | Grant (A) | +56,000 | $0 | EDGAR |
| 2023-06-22 | NKTX | Sell (S) | −439 | -$2.1K | EDGAR |
| 2023-01-18 | NKTX | Mixed | +36,385 | -$6.1K | EDGAR |
| 2022-08-17 | NKTX | Mixed | — | -$68.2K | EDGAR |
| 2022-06-21 | NKTX | Grant (A) | +5,000 | $0 | EDGAR |
| 2022-01-19 | NKTX | Grant (A) | +12,800 | $0 | EDGAR |
| 2021-08-04 | NKTX | Mixed | −1,350 | -$104.8K | EDGAR |